Edwards Lifesciences
497 hedge funds and large institutions have $9.47B invested in Edwards Lifesciences in 2014 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 157 increasing their positions, 163 reducing their positions, and 20 closing their positions.
370% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 20
100% more funds holding in top 10
Funds holding in top 10: 5 → 10 (+5)
27% more call options, than puts
Call options by funds: $44.2M | Put options by funds: $34.7M
17% more capital invested
Capital invested by funds: $8.09B → $9.47B (+$1.38B)
16% more funds holding
Funds holding: 429 → 497 (+68)
4% less repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 163
13.1% less ownership
Funds ownership: 536.02% → 522.92% (-13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Generation Investment Management
London,
United Kingdom
|
+$123M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$91.3M |
| 3 |
Two Sigma Investments
New York
|
+$66.6M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$58.9M |
| 5 |
JP Morgan Chase
New York
|
+$50.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$582M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$168M |
| 3 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
-$119M |
| 4 |
FC
Fairpointe Capital
Chicago,
Illinois
|
-$86.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$69.8M |
EW Hedge Fund Activity: Q3 2014 in Review
497 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q3 2014, worth a combined $9.47B — up 17% from $8.09B a quarter earlier.
Buyers outnumbered sellers: 94 funds opened new EW positions and 20 closed out — a net gain of 74 holders — while 157 added to existing stakes and 163 trimmed.
The largest buyer was Generation Investment Management, adding an estimated $123M. The largest seller was Capital World Investors, cutting an estimated $582M.
- 497 institutional investors held Edwards Lifesciences (EW) as of Q3 2014, up from 429 in Q2 2014.
- Funds reported $9.47B of Edwards Lifesciences stock for Q3 2014, up 17% quarter-over-quarter.
- 94 funds opened new Edwards Lifesciences positions in Q3 2014 and 20 closed out, a net change of +74 holders.
- The largest Edwards Lifesciences buyer in Q3 2014 was Generation Investment Management, an estimated $123M added.
- The largest Edwards Lifesciences seller in Q3 2014 was Capital World Investors, an estimated $582M sold.
Based on aggregated 13F filings for Q3 2014.